Renishaw is pleased to announce that the first neurosurgical robotic procedure with its NeuroMate® stereotactic system has taken place at the Neurosurgery Department of Hospital Nacional Guillermo Almenara in Lima, Peru. This is the first South American installation of NeuroMate, which provides cutting-edge robotic technology that enables neurosurgeons to deliver field proven neuro-implantable devices with pinpoint accuracy.
Dr. Luis Bromley, Chief of the Neurovascular and Tumour Surgical Department at the Neurosurgery Department said, "The NeuroMate surgical robot provides our department a platform solution for planning and executing a broad range of stereotactic neurosurgical procedures. We expect to enhance the safety and cost-effectiveness of these interventions, while improving patient outcomes through the accuracy and reliability of the system."
"The NeuroMate integrated very nicely in our surgical workflow and the benefits of having a robotic assistant in the OR were evident in our first experience", added Dr. Camilo Contreras Campana, who performed the first NeuroMate procedure in the hospital.
Dr. Abed Hammoud, CEO of Renishaw Mayfield SA said, "This installation confirms once again the trust of functional neurosurgeons worldwide in the proven performance of the NeuroMate robot. Our training and clinical support teams worked closely with Dr Bromley, Dr Contreras Campana, and the hospital staff to ensure the seamless integration of the NeuroMate into their procedure workflow, thus aiding surgeons to provide positive outcomes for their patients."
For further information on our Neurological products please visit www.renishaw.com/neurological
The parent company of the Renishaw Group is Renishaw plc, registered in England no. 1106260. Registered Office: New Mills, Wotton-under-Edge, Gloucestershire, UK.
Copyright © 2001-2012 Renishaw plc